Anonymous
Guest
Anonymous
Guest
Hmmmmmmm........dare we ask or dare we answer?
NCM is just another example of Merck losing its focus. My hope is that Merck will pull its head out of it’s ....and hire a CEO that is an MD. The sooner Merck realizes that the commercial model conflict’s itself. The sooner we can move forward.
So true. Lawyers have driven us down and keep us there. Things are screwed up when you cannot even mention a success or product on MVX. WTF?
Thank God for small favors. I really don't need to hear or have to listen to some other rep's "success story" thank you. John Horan was a lawyer and as I recall, Merck's rise was building steam under his CEO leadership. We didn't always have MD's.
NCM's success was the reduction of sales force. Merck used the NCM as a brand name to sell the down sizing of the sales force. It was nothing more than that.
Any decent sales rep would know you have to partner with key customers to be successful. What's so special about that with NCM then?
Just something new to try out. Give it a while longer then something else will start. Look at this industry, its a constant bounce to new ideas, they fail, then onto something else. Keeps people in HDQ busy.
Thought I heard where you guys had resurrected the old "System of Opportunity" and "Physicians of Opportunity" program. Otherwise known as SOO and POO. That was around 25 years ago. Did it really get brought back? I was lucky to have had a very cool DM who knew how to manage and roll with the BS that got pooped out of WP. Then there were reps who had bastards for DM's that got axed over their weak implementation of the soo-poo program. What happened at Merck 25 years ago that made no sense then continues to this day I suspect under the same shit-different name program. The more things change, the more they really do stay the same.
My wacky manager insisted that I took along that wall poster size "System of Opportunities" along whenever he rode with me. He decided he to visually verify that I had names of targeted physicians on it and what I planned to do with each.
I still wish my second career will be repackaging this kind of shit and sell it to the current Merck management and make some $$. IMS has been repackaging flimsy data for years and drug companies keep buying them. One doc friend showed me this booklet which he filled out to cash in for a prize. He sometimes asked his nurse to fill them out. IMS collected this crappy data, issued a report, say, "The current prescribing habits of primary care physicians in the treatment of hypertension" and every company rushes to buy a copy.